Pluri Secures $3.0M via Registered Direct Offering at $1.50 Per Share
PLUR is trading near its 52-week low of $1.45 (7.6% above the low) on elevated volume (3.5× avg).
Summary
Pluri Inc. raised approximately $3.0 million in net proceeds through a registered direct offering of 1.2 million shares at $1.50, plus pre-funded and common warrants, to fund working capital amid a severe liquidity crisis.
Key Events · Financing and Capital Events · PLUR
-
Registered Direct Offering
Pluri agreed to sell 1,200,000 common shares at $1.50 per share and pre-funded warrants for 1,028,940 shares at $1.49999 per warrant, with expected net proceeds of approximately $2,984,808.
-
Warrant Overhang
The offering includes common warrants to purchase 2,228,940 shares at $1.65 per share, exercisable after six months for five years, adding significant potential dilution.
-
Liquidity Crisis Context
The raise comes as Pluri faces less than three months of cash runway and an imminent $27.4 million EIB loan maturity, as previously disclosed in its last 10-Q.
-
Placement Agent Terms
A.G.P./Alliance Global Partners will receive a 6.50% cash fee on gross proceeds plus up to $50,000 in expense reimbursements.
Analysis · PLUR · Life Sciences
On August 26, 2026, Pluri Inc. entered into a securities purchase agreement to raise approximately $3.0 million in net proceeds through a registered direct offering of 1.2 million common shares at $1.50 per share, plus pre-funded warrants for 1,028,940 shares and common warrants for 2,228,940 shares at a $1.65 exercise price. The offering is expected to close on August 28, 2026. This capital raise is critical for a company facing an acute liquidity crisis with less than three months of cash runway and an imminent $27.4 million EIB loan maturity, as previously disclosed. The offering provides immediate working capital but adds significant potential dilution through the warrants, which could increase the share count by over 2.2 million shares if exercised. The 6.50% placement agent fee and $50,000 expense reimbursement are standard for a distressed micro-cap raise. The 45-day lock-up on company issuances and 6-month prohibition on variable rate transactions are typical protective covenants for the investor.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1758 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.05%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $1.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $1.45 to $5.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.